[Synthesis and release of N-acetylaspartyl glutamate (NAAG) in medial giant axons in crayfish].
Studies of crayfish Medial Giant nerve Fiber suggested that glutamate (GLU) released from the axon during action potential generation initiates metabolic and electrical responses of periaxonal glia. This investigation sought to elucidate the mechanism of GLU appearance extracellularly following axon stimulation. Axoplasm and periaxonal glial sheath from nerve fibers incubated with radiolabelled L-GLU contained radiolabeled GLU, glutamine (GLN), GABA, aspartate (ASP), and NAAG. Total radiolabel release was not altered by electrical stimulation of nerve cord loaded with [14C]-GLU by bath application or loaded with [14C]-GLU, [3H]-D-ASP, or [3H]-NAAG by axonal injection. However, radioactivity distribution among GLU and its metabolic products in the superfusate was changed, with NAAG accounting for the largest fraction. In axons incubated with radiolabeled GLU, the stimulated increase in radioactive NAAG in the superfusate coincided with the virtual clearance of radioactive NAAG from the axon. The increase in [3H]-GLU in the superfusion solution that was seen upon stimulation of nerve bathloaded with [3H]-NAAG was reduced when beta-NAAG, a competitive NAALADase inhibitor, was present. Together, these results suggest that some GLU is metabolized to NAAG in the giant axon and its periaxonal glia and that, upon stimulation, NAAG is released and converted to GLU by NAALADase. A quisqualate-, beta-NAAG-sensitive NAALADase activity was detected in nerve cord homogenates. Stimulation or NAAG administration in the presence of NAALADase inhibitor caused a transient hyperpolarization of the periaxonal glia comparable to that produced by L-GLU. The results implicate N-acetylaspartylglutamate (NAAG) and GLU as potential mediators. of the axon-glia interactions.
Urazaev
A Kh
AKh
Department of Physiology, East Carolina University School of Medicine, Greenville, NC 27858b, USA.
Gafurov
B Sh
BSh
Grossfeld
R M
RM
Fletcher
P L
PL
Lieberman
E M
EM
D000200:Action Potentials; D001369:Axons / Q000187:drug effects / Q000378:metabolism*; D002268:Carboxypeptidases / Q000037:antagonists & inhibitors / Q000378:metabolism; D002462:Cell Membrane / Q000502:physiology; D002851:Chromatography, High Pressure Liquid; D004151:Dipeptides / Q000378:metabolism* / Q000494:pharmacology; D004558:Electric Stimulation; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005110:Extracellular Space / Q000378:metabolism; D017952:Ganglia, Invertebrate / Q000187:drug effects / Q000378:metabolism / Q000648:ultrastructure; D043425:Glutamate Carboxypeptidase II; D018698:Glutamic Acid / Q000378:metabolism; D006868:Hydrolysis; D066298:In Vitro Techniques; D009457:Neuroglia / Q000378:metabolism / Q000648:ultrastructure
D004151:Dipeptides; D004791:Enzyme Inhibitors; C027172:isospaglumic acid; D018698:Glutamic Acid; D002268:Carboxypeptidases; D043425:Glutamate Carboxypeptidase II